SEC Comment Letter 0000000000-23-000435 to PARDES BIOSCIENCES, INC. (CIK 0001822711)
PARDES BIOSCIENCES, INC. (CIK 0001822711)
Date: Jan. 17, 2023 · CIK: 0001822711 · Accession: 0000000000-23-000435
AI Filing Summary & Sentiment
File numbers found in text: 333-269192
Letter
United States securities and exchange commission logo January 17, 2023 Elizabeth Lacy General Counsel and Corporate Secretary Pardes Biosciences, Inc. 2173 Salk Avenue, Suite 250 PMB#052 Carlsbad, CA 92008 Re:Pardes Biosciences, Inc. Registration Statement on Form S-3 Filed January 12, 2023 File No. 333-269192 Dear Elizabeth Lacy: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Jimmy McNamara at 202-551-7349 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Jennifer Hitchcock
Show Raw Text
United States securities and exchange commission logo
January 17, 2023
Elizabeth Lacy
General Counsel and Corporate Secretary
Pardes Biosciences, Inc.
2173 Salk Avenue, Suite 250
PMB#052
Carlsbad, CA 92008
Re:Pardes Biosciences, Inc.
Registration Statement on Form S-3
Filed January 12, 2023
File No. 333-269192
Dear Elizabeth Lacy:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Jimmy McNamara at 202-551-7349 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Jennifer Hitchcock